Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

XKRY2 Inhibitors

The XKRY2 inhibitors represent a class of chemical entities dedicated to modulating the activity or expression of the XKRY2 protein, which is known to be a Y-linked gene with specific roles in mammalian cells. As the precise physiological function of XKRY2 is still under extensive study, these inhibitors have piqued the interest of researchers aiming to elucidate the broader roles of Y-linked genes in cellular processes. By inhibiting XKRY2, these chemical agents grant scientists a tool to discern the direct and indirect contributions of this protein to cellular events and phenotypes. While the exact modes of action of these inhibitors may vary, they generally aim to reduce the expression or activity of XKRY2 either at the transcriptional, post-transcriptional, or protein-functional level.

Molecules that belong to the XKRY2 inhibitor class could operate through a myriad of mechanisms. Some might bind directly to the XKRY2 protein, altering its conformation and consequently, its function. Others could influence the upstream regulatory pathways that dictate the expression of the XKRY2 gene, resulting in lowered transcript levels. Additionally, post-transcriptional regulators could hinder the translation of XKRY2 mRNA or expedite the degradation of the XKRY2 protein. The diversity in potential mechanisms emphasizes the versatility of this chemical class. As research progresses, the refinement and categorization of XKRY2 inhibitors, based on their specific modes of action, will be pivotal in harnessing their full potential for scientific exploration.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

By causing DNA breaks via topoisomerase II inhibition, etoposide could disrupt the accessibility or transcriptional integrity of the XKRY2 gene.

Teniposide

29767-20-2sc-204910
sc-204910A
25 mg
100 mg
$73.00
$235.00
6
(1)

Similar to etoposide, teniposide might interfere with XKRY2 gene transcription by inducing DNA damage.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

As a pyrimidine analog, 5-FU may incorporate into the XKRY2 transcript, potentially leading to faulty RNA processing or degradation.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

By limiting thymidine production, methotrexate could indirectly hinder the replication and transcription of the XKRY2 gene.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

If XKRY2 expression is modulated by certain kinases, genistein might inhibit those pathways and thereby reduce XKRY2 transcription.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

If XKRY2 is regulated via PI3K-dependent pathways, LY294002 could suppress its transcription by inhibiting PI3K.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

By inhibiting various protein kinases, staurosporine could alter signaling pathways that modulate XKRY2 transcription.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

Zebularine might modify the methylation state around the XKRY2 locus, possibly leading to altered gene transcription.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor; if XKRY2's expression is PI3K-dependent, wortmannin might hinder its transcription.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

If XKRY2 transcription is influenced by EGFR signaling, AZD9291 could impact its expression through EGFR pathway inhibition.